Myeloma Paper of the Day, June 5th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Inference of genomic lesions from single-cell RNAseq in myeloma improves functional intra- and inter-clonal analysis. If costs were lower and processing time was quicker, this could be part of our standard patient evaluation.
Source: Robert Orlowski/X
Authors: Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano, Alfredo Marchetti, Sonia Fabris, Stefania Pioggia, Ilaria Silvestris, Domenica Ronchetti, Silvia Lonati, Giuseppina Fabbiano, Valentina Traini, Elisa Taiana, Laura Porretti, Federico Simone Colombo, Claudio De Magistris, Margherita Scopetti, Marzia Barbieri, Loredana Pettine, Federica Torricelli, Dr, Antonino Neri, Dr, Francesco Passamonti, Marta Lionetti, Matteo Claudio Da Via’, and Niccolò Bolli.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
